Non-Coding RNAs as New Therapeutic Targets in the Context of Renal Fibrosis
AbstractFibrosis, or tissue scarring, is defined as the excessive, persistent and destructive accumulation of extracellular matrix components in response to chronic tissue injury. Renal fibrosis represents the final stage of most chronic kidney diseases and contributes to the progressive and irreversible decline in kidney function. Limited therapeutic options are available and the molecular mechanisms governing the renal fibrosis process are complex and remain poorly understood. Recently, the role of non-coding RNAs, and in particular microRNAs (miRNAs), has been described in kidney fibrosis. Seminal studies have highlighted their potential importance as new therapeutic targets and innovative diagnostic and/or prognostic biomarkers. This review will summarize recent scientific advances and will discuss potential clinical applications as well as future research directions. View Full-Text
Share & Cite This Article
Van der Hauwaert, C.; Glowacki, F.; Pottier, N.; Cauffiez, C. Non-Coding RNAs as New Therapeutic Targets in the Context of Renal Fibrosis. Int. J. Mol. Sci. 2019, 20, 1977.
Van der Hauwaert C, Glowacki F, Pottier N, Cauffiez C. Non-Coding RNAs as New Therapeutic Targets in the Context of Renal Fibrosis. International Journal of Molecular Sciences. 2019; 20(8):1977.Chicago/Turabian Style
Van der Hauwaert, Cynthia; Glowacki, François; Pottier, Nicolas; Cauffiez, Christelle. 2019. "Non-Coding RNAs as New Therapeutic Targets in the Context of Renal Fibrosis." Int. J. Mol. Sci. 20, no. 8: 1977.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.